109191 ⎘
Structure or type of the nucleic acid; Chemical structure; Spatial arrangement of the modifications having a combination of backbone and sugar modifications
MODULATION OF APOLIPOPROTEIN(A) EXPRESSION
#902Targeting microRNAs for the treatment of liver cancer
#903MODULATION OF HEPATITIS B VIRUS (HBV) EXPRESSION
#904Modulation of glucagon receptor expression
#905Proinflammatory nucleic acids
#906Antisense modulation of PTP1B expression
#907Structure and use of 5′ phosphate oligonucleotides
#908Method of inhibiting miR-33 using a modified oligonucleotide
#909Modulation of eIF4E expression
#910Modulation of signal transducer and activator of transcription 3 (STAT3)expression
#911MODULATION OF TTC39 EXPRESSION TO INCREASE HDL
#912MicroRNA as a cancer progression predictor and its use for treating cancer
#913Oligonucleotide complex compositions and methods of use as gene alteration tools
#914Modulation of huntingtin expression
#915MODULATION OF DIACYLGLYCEROL ACYLTRANSFERASE 1 EXPRESSION
#916Compositions and methods for prognosis and treatment of prostate cancer
#917Methods for slowing familial ALS disease progression
#918MODULATION OF FACTOR 7 EXPRESSION
#919COMPOSITIONS AND METHODS FOR THE MODULATION OF JNK PROTEINS
#920Antisense oligonucleotide modulation of STAT3 expression
#921RNAi probes targeting cancer-related proteins
#922Antisense oligonucleotides
#923MODULATION OF SGLT-2 EXPRESSION
#924MicroRNA inhibitors comprising locked nucleotides
#925Lipid formulation
#926Chemical modification of short small hairpin RNAs for inhibition of gene expression
#927Compositions and methods for inhibiting expression of RRM2 genes
#928Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#929MODULATION OF EIF4E-BP2
#930ANTISENSE OLIGONUCLEOTIDE MODULATION OF RAF GENE EXPRESSION
#931MODULATION OF TRANSTHYRETIN EXPRESSION
#932SOLUBLE THF RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
#933Targeting MicroRNAs for metabolic disorders
#934Methods for enhancing utrophin production via inhibition of microRNA
#935Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#936Treatment of neurological disorders
#937Modulation of STAT 6 expression
#938COMPOSITIONS AND THEIR USES DIRECTED TO HEPCIDIN
#939ANTISENSE MODULATION OF APOLIPOPROTEIN B EXPRESSION
#940Oligomeric compounds and compositions for the use in modulation of target nucleic acids
#941METHODS OF MODULATING AN IMMUNE RESPONSE TO A VIRAL INFECTION
#942MODULATION OF INFLAMMATORY RESPONSES BY FACTOR XI
#943Antisense modulation of C-reactive protein expression
#944Antisense modulation of PTP1B expression
#945Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means
#946Method for inhibiting the activity of mir-155
#947Short interfering ribonucleic acid (siRNA) for oral administration
#948Short interfering ribonucleic acid (siRNA) for oral administration
#949Antisense modulation of superoxide dismutase 1, soluble expression
#950Short interfering ribonucleic acid (siRNA) for oral administration
#951Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrophy pre-mRNA
#952ANTISENSE MODULATION OF CHOLESTERYL ESTER TRANSFER PROTEIN EXPRESSION
#953Compositions And Methods For Increasing Cellular Uptake Of RNAi Via SID-1
#954Modulation of exon recognition in pre-mRNA by interfering RNA structure
#955Compositions and their uses directed to huntingtin
#956RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
#957RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
#958Means and methods for counteracting muscle disorders
#959Compositions and methods for inhibiting expression of the HAMP gene
#960RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
#961METHODS AND MEANS FOR EFFICIENT SKIPPING OF AT LEAST ONE OF THE FOLLOWING EXONS OF THE HUMAN DUCHENNE MUSCULAR DYSTROPHY GENE: 43, 46, 50-53
#962Targeting MicroRNAs For The Treatment Of Liver Cancer
#963SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
#964Modulation of C-reactive protein expression
#965Oligomeric compounds and compositions for use in modulation of small non-coding RNAS
#966ANTISENSE MODULATION OF STEAROYL-COA DESATURASE EXPRESSION
#967ENHANCED ANTISENSE OLIGONUCLEOTIDES
#968Modulation of HIF1α and HIF2α expression
#969Methods and means for treating DNA repeat instability associated genetic disorders
#970RNAi modulation of SCAP and therapeutic uses thereof
#971Potent LNA oligonucleotides for the inhibition of HIF-1A expression
#972METHODS FOR MODULATING EXPRESSION OF CREB
#973Conjugates For Use In Hepatocyte Free Uptake Assays
#974Complement antagonists and uses thereof
#975Modulation of glucose-6-phosphatase translocase expression
#976Modulation of CD40 expression
#977Bispecific oligonucleotide for the treatment of CNS malignancies
#978Modulation of SMRT expression
#979RNAi-mediated inhibition of tumor necrosis factor α-related conditions
#980Compositions and their uses directed to acetyl-CoA carboxylases
#981Antiviral Oligonucleotides Having a Conserved G4 Core Sequence
#982Methods for modulating expression of RBP4
#983Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
#984Interfering RNA molecules
#985Antisense modulation of C-reactive protein expression
#986Compositions and their uses directed to PTPRU
#987Oligomeric compounds comprising bicyclic nucleosides and having reduced toxicity
#988Double-stranded RNA directed to CASP2 and methods of use thereof
#989SOLUBLE TNF RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
#990ANTISENSE MODULATION OF BCL2-ASSOCIATED X PROTEIN EXPRESSION
#991RNA antagonist compounds for the modulation of PIK3CA expression
#992RNAi Modulation of the RHO-A Gene and Uses Thereof
#993RNA interference mediated inhibition of muscarinic colinergic receptor gene expression using short interfering nucleic acid (siNA)
#994Modulation of apolipoprotein C-III expression
#995MODULATION OF FACTOR 9 EXPRESSION
#996Method for reducing scarring during wound healing using antisense compounds directed to CTGF
#997Antisense oligonucleotide modulation of STAT3 expression
#998DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION
#999Modulation of apolipoprotein (a) expression
#1000Chimeric oligomeric compounds for modulation of splicing
#1001TRPM-2 antisense therapy
#1002RNAi probes targeting cancer-related proteins
#1003Antisense oligonucleotides targeted to the coding region of thymidylate synthase and uses thereof
#1004EFFECTS OF APOLIPOPROTEIN B INHIBITION ON GENE EXPRESSION PROFILES IN ANIMALS
#1005METHODS AND COMPOSITONS FOR ANTISENSE VEGF OLIGONUCLEOTIDES
#1006Modulation of SGLT2 expression
#1007Lipid formulation
#1008RNA Antagonist Compounds for the Modulation of MCL-1
#1009MODULATION OF HIF1 BETA EXPRESSION
#1010Modulation of forkhead box O1A expression
#1011RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA)
#1012RNA INTERFERENCE MEDIATED INHIBITION OF ADENOSINE A1 RECEPTOR (ADORA1) GENE EXPRESSION USING SHORT INTERFERING RNA
#1013Administering antisense oligonucleotides complementary to human apolipoprotein B
#1014Antisense modulation of fibroblast growth factor receptor 4 expression
#1015Micro-RNA family that modulates fibrosis and uses thereof
#1016Modulation of apolipoprotein (A) expression
#1017Targeting microRNAs for the treatment of liver cancer
#1018Method for inhibiting the activity of mir-155
#1019Oligomeric compounds and compositions for use in modulation of pri-miRNAs
#1020Antisense modulation of kinesin-like 1 expression
#1021MODULATION OF GLUCAGON RECEPTOR EXPRESSION
#1022RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
#1023Chemically modified oligonucleotides for use in modulation micro RNA and uses thereof
#1024MODULATION OF GLUCOCORTICOID RECEPTOR EXPRESSION
#1025Compositions and methods for inhibiting expression of the HAMP gene
#1026Modulation of Stat 6 Expression for the Treatment of Airway Hyperresponsiveness
#1027ANTISENSE MODULATION OF ACYL COA CHOLESTEROL ACYLTRANSFERASE-2 EXPRESSION
#1028Antisense compounds
#1029METHODS AND MEANS FOR TREATING DNA REPEAT INSTABILITY ASSOCIATED GENETIC DISORDERS
#1030RNAi modulation of SCAP and therapeutic uses thereof
#1031RNA interference mediated inhibition of protein tyrosine phosphatase-1B (PTP-1B) gene expression using short interfering nucleic acid (siNA)
#1032STRUCTURE AND USE OF 5'PHOSPHATE OLIGONUCLEOTIDES
#1033RNA interference mediated treatment of alzheimer's disease using short interfering nucleic acid (siNA)
#1034RNAi-MEDIATED INHIBITION OF TUMOR NECROSIS FACTOR ALPHA-RELATED CONDITIONS
#1035Pharmaceutical composition
#1036MODULATION OF SID-1 EXPRESSION
#1037OLIGORIBONUCLEOTIDES AND RIBONUCLEASES FOR CLEAVING RNA
#1038Methods for treating hypercholesterolemia
#1039Modulation of factor 11 expression
#1040Pure miRNA Sample Preparation Method
#1041Antisense oligonucleotides directed against connective tissue growth factor and uses thereof
#1042MODULATION OF eIF4E EXPRESSION
#1043Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly or abnormally expressed gene
#1044Methods for treating multiple sclerosis using antisense oligonucleotides
#1045Modulation of HIF1-beta expression
#1046RNA interference mediated inhibition of muscarinic colinergic receptor gene expression using short interfering nucleic acid (siNA)
#1047COMPOUNDS AND METHODS FOR MODULATING PROTEIN EXPRESSION
#1048Tripartite oligonucleotide complexes and methods for gene silencing by RNA interference
#1049Compositions and Methods for Inhibiting Expression of Eg5 and VEGF Genes
#1050METHODS FOR SLOWING FAMILIAL ALS DISEASE PROGRESSION
#1051COMPOSITIONS AND THEIR USES DIRECTED TO HUNTINGTIN
#1052Combination therapy using budesonide and antisense oligonucleotide targeted to IL4-receptor alpha
#1053EFFICIENT REDUCTION OF TARGET RNA'S BY SINGLE- AND DOUBLE-STRANDED OLIGOMERIC COMPOUNDS
#1054Antisense modulation of connective tissue growth factor expression
#1055Short interfering ribonucleic acid (siRNA) with improved pharmacological properties
#1056ANTISENSE MODULATION OF APOLIPOPROTEIN B EXPRESSION
#1057Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#1058CONJUGATED DOUBLE STRAND COMPOSITIONS FOR USE IN GENE MODULATION
#1059Regulation of epigenetic control of gene expression
#1060Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#1061MODULATION OF STAT 6 EXPRESSION
#1062Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#1063Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#1064Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs
#1065Potent LNA oligonucleotides for the inhibition of HIF-1a expression
#1066Modulation of insulin like growth factor I receptor expression
#1067RNA interference mediated inhibition of respiratory syncytial virus (RSV) expression using short interfering nucleic acid (siNA)
#1068Antisense modulation of C-reactive protein expression
#1069MODULATION OF TUDOR-SN EXPRESSION
#1070HUMAN RNASE III AND COMPOSITIONS AND USES THEREOF
#1071Conjugates and compositions for cellular delivery
#1072DELIVERY OF POLYNUCLEOTIDE AGENTS TO THE CENTRAL NERVOUS SYSTEM
#1073RNA INTERFERENCE MEDIATED INHIBITION OF B-CELL CLL/LYMPHOMA-2 (BCL2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
#1074RNA Interference Mediated Inhibition of Adenosine A1 Receptor (ADORA1) Gene Expression Using Short Interfering Nucleic Acid (siNA)
#1075RNA INTERFERENCE MEDIATED INHIBITION OF PROTEIN TYROSINE PHOSPHATASE-1B (PTP-1B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
#1076Induction of exon skipping in eukaryotic cells
#1077Oligomeric compounds and compositions for the use in modulation of microRNAs
#1078MODULATION OF LMW-PTPASE EXPRESSION
#1079COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE HAMP GENE
#1080Modulation of eIF4E-BP2 expression
#1081MIR-150 FOR THE TREATMENT OF BLOOD DISORDERS
#1082RNA antagonist compounds for the modulation of PIK3CA expression
#1083Modulation of eIF4E expression
#1084RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCELIC ACID (siNA)
#1085RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)
#1086MODULATION OF STAT 6 EXPRESSION FOR THE TREATMENT OF AIRWAY HYPERRESPONSIVENESS
#1087Interfering RNA molecules
#1088Modulation of C-reactive protein expression
#1089MODULATION OF ENDOTHELIAL LIPASE EXPRESSION
#1090RNA interference mediated inhibition of hepatitis C virus (HCV) gene expression using short interfering nucleic acid (siNA)
#1091RNA interference mediated inhibition of telomerase gene expression using short interfering nucleic acid (siNA)
#1092RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)
#1093RNA Interference Mediated Inhibition of Acetyl-CoA-Carboxylase Gene Expression Using Short Interfering Nucleic Acid (siNA)
#1094RNA interference mediated inhibition of cyclin D1 gene expression using short interfering nucleic acid (siNA)
#1095RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (SINA)
#1096RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATION CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
#1097RNA interference mediated inhibition of polycomb group protein EZH2 gene expression using short interfering nucleic acid (siNA)
#1098Antisense modulation of PTP1B expression
#1099RNA ANTAGONIST COMPOUNDS FOR THE INHIBITION OF APO-B100 EXPRESSION
#1100MODULATION OF INSULIN LIKE GROWTH FACTOR I RECEPTOR EXPRESSION
#1101Modulation of diacylglycerol acyltransferase 1 expression
#1102RNA interference mediated inhibition of muscarinic colinergic receptor gene expression using short interfering nucleic acid (siNA)
#1103RNA interference mediated inhibition of Stearoyl-CoA desaturase (SCD) gene expression using short interfering nucelic acid (siNA)
#1104RNA interference mediated inhibition of MYC and/or MYB gene expression using short interfering nucleic acid (siNA)
#1105RNA interference mediated inhibition of XIAP gene expression using short interfering nucleic acid (siNA)
#1106RNAi modulation of SCAP and therapeutics uses thereof
#1107Modulation of eIF4E-BP2 expression
#1108Modulation of transthyretin expression
#1109Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure
#1110Modulation of apolipoprotein (a) expression
#1111Topical administrations of antisense compounds to VLA-4 for the treatment of respiratory conditions
#1112RNA Interference Mediated Inhibition of MAP Kinase Gene Expression or Expression of Genes Involved in MAP Kinase Pathway Using Short Interfering Nucleic Acid (SiNA)
#1113RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
#1114Antisense oligonucleotides for prevention of metastasis formation of cancer cells
#1115Antisense oligonucleotides against thymidylate synthase
#1116Isis Pharmaceuticals, Inc.
#1117Pharmaceutical Composition Containing Meltrin Antagonist
#1118Oligonucleotide complex compositions and methods of use as gene alteration tools
#1119Compositions and their uses directed to PTPRU
#1120RNAi probes targeting cancer-related proteins
#1121Compositions and methods for the modulation of JNK proteins
#1122Antisense modulation of apolipoprotein B expression
#1123Induction of exon skipping in eukaryotic cells
#1124Compositions and methods for optimizing cleavage of RNA by RNase H
#1125Method For Preventing or Treating Pain in a Mammal
#1126Antisense modulation of p38 mitogen activated protein kinase expression
#1127Oligomeric compounds for the modulation ras expression
#1128RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)
#1129ANTISENSE MODULATION OF ACYL COA CHOLESTEROL ACYLTRANSFERASE-2 EXPRESSION
#1130Modulation of FR-alpha expression
#1131Modulation of forkhead box O1A expression
#1132Antisense modulation of stearoyl-CoA desaturase expression
#1133Double Strand Compositions Comprising Differentially Modified Strands for Use in Gene Modulation
#1134Clusterin antisense therapy for treatment of cancer
#1135Duplex oligonucleotide complexes and methods for gene silencing by RNA interference
#1136TRPM-2 antisense therapy
#1137ANTISENSE OLIGONUCLEOTIDE MODULATION OF STAT3 EXPRESSION
#1138Compositions and their uses directed to huntingtin
#1139RETROGRADE TRANSPORT OF SIRNA AND THERAPEUTIC USES TO TREAT NEUROLOGIC DISORDERS
#1140Polycationic compositions for cellular delivery of polynucleotides
#1141RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)
#1142Antisense modulation of kinesin-like 1 expression
#1143BACKBONE MODIFICATIONS TO MODULATE OLIGONUCLEOTIDE TARGETING IN VIVO
#1144COMPOSITIONS AND THEIR USES DIRECTED TO HUNTINGTIN
#1145Human RNase H1 oligonucleotide compositions thereof
#1146RNAI-mediated inhibition of tumor necrosis factor α-related conditions
#1147Compositions and their uses directed to hepcidin
#1148THERAPEUTIC DRUG COMBINATIONS AND DELIVERY SYSTEMS COMPRISING C-RAF KINASE ANTISENSE POLYNUCLEOTIDES FOR TREATING OCULAR DISEASES AND DISORDERS
#1149Modulation of telomere length by oligonucleotides having a G-core sequence
#1150Rna Interference Mediated Inhibition of Severe Acute Respiratory Syndrome (Sars) Gene Expression Using Short Interfering Nucleic Acid
#1151MODULATION OF THYROID HORMONE RECEPTOR INTERACTOR 3 EXPRESSION
#1152Soluble TNF receptors and their use in treatment of disease
#1153Modulation of glucagon receptor expression
#1154MODULATION OF GLUCAGON RECEPTOR EXPRESSION
#1155MODULATION OF GLUCAGON RECEPTOR EXPRESSION
#1156MODULATION OF GLUCAGON RECEPTOR EXPRESSION
#1157MODULATION OF ACE2 EXPRESSION
#1158Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
#1159Data correction apparatus, data correction method, magnetic resonance imaging apparatus and X-ray CT apparatus
#1160Pharmaceutical composition
#1161DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION
#1162DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION
#1163Modulation of ace2 expression
#1164Rna interference mediated inhibition of nogo and nogo receptor gene expression using short interfering nucleic acid (sina)
#1165DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION
#1166DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION
#1167DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION
#1168DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION
#1169Antisense IAP nucleobase oligomers and uses thereof
#1170DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION
#1171DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION
#1172DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION
#1173RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
#1174DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION
#1175DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION
#1176DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION
#1177DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION
#1178RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA)
#1179Antisense modulation of acyl CoA cholesterol acyltransferase-2 expression
#1180Antisense IAP oligonucleotides and uses thereof
#1181Antisense IAP nucleobase oligomers and uses thereof
#1182DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION
#1183Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
#1184Antisense IAP oligonucleotides and uses thereof
#1185Oligonucleotides targeting prion diseases
#1186Methods for slowing familial ALS disease progression
#1187Inhibition of histone deacetylase
#1188Splice switch oligomers for TNF superfamily receptors and their use in treatment of disease
#1189Rna interference mediated inhibition of xiap gene expression using short interfering nucleic acid (sina)
#1190Modulation of glucagon receptor expression
#1191Modulation of glucocorticoid receptor expression
#1192Modulation of eIF4E expression
#1193Pure miRNA Sample Preparation Method
#1194Antisense modulation of superoxide dismutase 1, soluble expression
#1195Methods for use in modulating miR-122a
#1196Antisense modulation of fibroblast growth factor receptor 3 expression
#1197Antisense IAP nucleobase oligomers and uses thereof
#1198RNAi modulation of the Rho-A gene in research models
#1199iRNA agents targeted to the Rho-A gene
#1200Antisense IAP nucleobase oligomers and uses thereof